ALTUN, B. Et Al. 2012. Use of Mesenchymal Stem Cells and Darbepoetin Improve Ischemia-Induced Acute Kidney Injury Outcomes. AMERICAN JOURNAL OF NEPHROLOGY , vol.35, no.6 , 531-539.

ALTUN, B., Yilmaz, R., Aki, T., Akoglu, H., Zeybek, D., Piskinpasa, S., ... Uckan, D.(2012). Use of Mesenchymal Stem Cells and Darbepoetin Improve Ischemia-Induced Acute Kidney Injury Outcomes. AMERICAN JOURNAL OF NEPHROLOGY , vol.35, no.6, 531-539.

ALTUN, BÜLENT Et Al. "Use of Mesenchymal Stem Cells and Darbepoetin Improve Ischemia-Induced Acute Kidney Injury Outcomes," AMERICAN JOURNAL OF NEPHROLOGY , vol.35, no.6, 531-539, 2012

ALTUN, BÜLENT Et Al. "Use of Mesenchymal Stem Cells and Darbepoetin Improve Ischemia-Induced Acute Kidney Injury Outcomes." AMERICAN JOURNAL OF NEPHROLOGY , vol.35, no.6, pp.531-539, 2012

ALTUN, B. Et Al. (2012) . "Use of Mesenchymal Stem Cells and Darbepoetin Improve Ischemia-Induced Acute Kidney Injury Outcomes." AMERICAN JOURNAL OF NEPHROLOGY , vol.35, no.6, pp.531-539.

@article{article, author={BÜLENT ALTUN Et Al. }, title={Use of Mesenchymal Stem Cells and Darbepoetin Improve Ischemia-Induced Acute Kidney Injury Outcomes}, journal={AMERICAN JOURNAL OF NEPHROLOGY}, year=2012, pages={531-539} }